Fisher & Paykel Healthcare (FSPKF) versus The Competition Critical Analysis

Fisher & Paykel Healthcare (OTCMKTS:FSPKF) is one of 87 publicly-traded companies in the “Medical Instruments & Supplies” industry, but how does it contrast to its rivals? We will compare Fisher & Paykel Healthcare to related businesses based on the strength of its analyst recommendations, profitability, valuation, institutional ownership, risk, earnings and dividends.

Institutional and Insider Ownership

31.4% of Fisher & Paykel Healthcare shares are owned by institutional investors. Comparatively, 40.8% of shares of all “Medical Instruments & Supplies” companies are owned by institutional investors. 22.4% of shares of all “Medical Instruments & Supplies” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Dividends

Fisher & Paykel Healthcare pays an annual dividend of $0.07 per share and has a dividend yield of 0.5%. Fisher & Paykel Healthcare pays out 38.5% of its earnings in the form of a dividend. As a group, “Medical Instruments & Supplies” companies pay a dividend yield of 2.2% and pay out 31.7% of their earnings in the form of a dividend. Fisher & Paykel Healthcare lags its rivals as a dividend stock, given its lower dividend yield and higher payout ratio.

Profitability

This table compares Fisher & Paykel Healthcare and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Fisher & Paykel Healthcare	N/A	N/A	N/A
Fisher & Paykel Healthcare Competitors	-45.70%	-207.71%	-6.01%

Analyst Ratings

This is a summary of recent ratings and target prices for Fisher & Paykel Healthcare and its rivals, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fisher & Paykel Healthcare	0	2	1	1	2.75
Fisher & Paykel Healthcare Competitors	413	1114	1407	46	2.36

As a group, “Medical Instruments & Supplies” companies have a potential upside of 33.48%. Given Fisher & Paykel Healthcare’s rivals higher probable upside, analysts plainly believe Fisher & Paykel Healthcare has less favorable growth aspects than its rivals.

Earnings and Valuation

This table compares Fisher & Paykel Healthcare and its rivals revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Fisher & Paykel Healthcare	N/A	N/A	73.39
Fisher & Paykel Healthcare Competitors	$959.07 million	$171.70 million	341.99

Fisher & Paykel Healthcare’s rivals have higher revenue and earnings than Fisher & Paykel Healthcare. Fisher & Paykel Healthcare is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Summary

Fisher & Paykel Healthcare rivals beat Fisher & Paykel Healthcare on 8 of the 13 factors compared.

Fisher & Paykel Healthcare Company Profile

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers adult respiratory products, including optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition, it provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.